Sexually transmitted infection (STI) risk in high risk patients is a common problem compounded by antimicrobial resistance. Join host, Geoff Wall, with guest Amanda Bushman, as they discuss a new post-exposure prophylaxis (PEP) therapy for STI prevention

The GameChanger
Sexually transmitted infection incidence is higher than most clinicians suspect. Doxycycline may offer effective post-exposure prophylaxis for some HIV positive patients.

Show Segments
[insert here]

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest
Amanda Bushman, PharmD, BCIDP
Clinical Pharmacist, UnityPoint Health

References and Resources

Luetkemeyer AF, Donnell D, Dombrowski JC, et al. Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections. N Engl J Med. 2023 Apr 6;388(14):1296-1306. doi: 10.1056/NEJMoa2211934. PMID: 37018493; PMCID: PMC10140182.

Redeem your CPE here
CPE (Pharmacist) https://learn.ceimpact.com/library/course/5768

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership https://www.ceimpact.com/

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the DOXY-PEP study
2. Apply results of DOXY-PEP to patient care

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-XXX-H01-P
Initial release date: XX/XX/2023
Expiration date: XX/XX/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!